Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Natriuretic peptides as indicators of cardiac remodeling in hypertensive patients
Blood Pressure, 07/01/09
Magnusson M et al. – Findings show that natriuretic peptide levels increased with increasing number of markers of cardiac remodeling. N-terminal pro-atrial natriuretic peptide (Nt-ANP) and brain natriuretic peptide (BNP) are useful to discriminate between pts for cardiac remodeling and may be considered a screening tool to select pts eligible for further examination with echocardiography.
Methods- Study of the relationship between 3 different natriuretic peptides and left ventricular mass, function, and diameter and kidney function in hypertensive pts
- Subjects: 139 consecutive pts with moderate hypertension
- Analysis of Nt-BNP, BNP, and N-terminal pro-atrial natriuretic peptide (Nt-ANP)
- Echocardiography to assess cardiac remodeling
- Cystatin C to assess glomerular filtration
- Stratification by extent of cardiac remodeling: 1) no remodeling; 2) 1 of left ventricular hypertrophy, left ventricular dysfunction or left ventricular dilatation; 3) 2 of above and 4) all 3 parameters
- All peptides differed significantly between groups with a continuous stepwise increase from groups 1 through 4
- Receiver operating characteristic analysis showed equal diagnostic performances for detection of any cardiac abnormalities for Nt-BNP and BNP; both superior to Nt-ANP
- In multivariable linear regression analysis, all 3 indicators of cardiac remodeling independently correlated with Nt-BNP and BNP
- Only left ventricular diameter independently correlated with Nt-ANP
Related Articles
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: Results from a phase II randomized, factorial, double-blind study of cediranib in patients with advanced solid tumors
Journal of Clinical Oncology, 11/13/09
Relevance Score: 94%
Practical strategies for management of hypertension in the elderly
Internet Source, 10/13/09
Relevance Score: 92%
Hypertension in Women: More Evidence for the Role of Lifestyle
Nursing for Women's Health, 10/12/09
Relevance Score: 92%
Hypertension treatment and management concerns in the elderly
Aging Health, 10/07/09
Relevance Score: 92%
Intradialytic Hypertension: A Less-Recognized Cardiovascular Complication of Hemodialysis
American Journal of Kidney Diseases, 10/28/09
Relevance Score: 91%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cyclooxygenase-2 (COX-2) G-765C is a protective factor for coronary artery disease but not for ischemic stroke: A meta-analysis
Atherosclerosis, 12/03/09
Induction of MIF expression by oxidized LDL via activation of NF-kB in vascular smooth muscle cells
Atherosclerosis, 12/03/09
Carbon monoxide (from CORM-2) inhibits high glucose-induced ICAM-1 expression via AMP-activated protein kinase and PPAR-gamma activations in endothelial cells
Atherosclerosis, 12/03/09
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Amlodipine/Valsartan/Hydrochlorothiazide: Fixed-Dose Combination in Hypertension
American Journal of Cardiovascular Drugs, 12/03/09
Impacts of Changes in Obesity Parameters for the Prediction of Blood Pressure Change in Japanese Individuals
Kidney and Blood Pressure Research, 12/03/09
O-GlcNAcylation Contributes to Augmented Vascular Reactivity Induced by Endothelin
Hypertension, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


